Prosecution Insights
Last updated: April 19, 2026

Sunovion Pharmaceuticals, Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18285975 TAAR1 AND SEROTONIN MODULATORS, AND PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF HERNANDEZ, JACKSON J 1627 Non-Final OA Oct 06, 2023
18284130 Computational Model and Methods for Selecting Clinical Trial Subjects to Reduce Heterogeneity PAULSON, SHEETAL R. 3615 Final Rejection Sep 26, 2023

Managing Sunovion Pharmaceuticals, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month